These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6736215)

  • 1. A study of potassium canrenoate on the raised intracranial pressure.
    Node Y; Yajima K; Nakazawa S
    Nihon Ika Daigaku Zasshi; 1984 Apr; 51(2):264-5. PubMed ID: 6736215
    [No Abstract]   [Full Text] [Related]  

  • 2. Canrenoate reversal of inhibitory effects of digoxin on basal and furosemide-stimulated renin secretion.
    Finotti P; Antonello A
    Clin Pharmacol Ther; 1982 Jul; 32(1):1-6. PubMed ID: 6282524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effect of captopril, canrenoate potassium, and atenolol. Relations with red blood cell sodium transport and renin.
    Niutta E; Cusi D; Colombo R; Tripodi G; Pellizzoni M; Pati P; Cesana B; Alberghini E; Barlassina C; Bianchi G
    Am J Hypertens; 1988 Oct; 1(4 Pt 1):364-71. PubMed ID: 3063286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and renal properties of potassium-sparing diuretics of the spirolactone group--I: Effects of SC-14266/371 (potassium canrenoate) on renal transport Na+, K+-ATPase activity.
    Osore H; Harrow TA
    Biochem Pharmacol; 1982 Dec; 31(24):4068-71. PubMed ID: 6130770
    [No Abstract]   [Full Text] [Related]  

  • 5. Spironolactone and potassium canrenoate in normal man.
    Ramsay L; Shelton J; Harrison I; Tidd M; Asbury M
    Clin Pharmacol Ther; 1976 Aug; 20(2):167-77. PubMed ID: 780038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of repeated administration of potassium canrenoate (SC-14266) on serum gonadotrophin, prolactin, testosterone and progesterone in male rats.
    Muraki T; Nakadate T; Kubota K; Tokunaga Y; Kato R
    Experientia; 1980 Jun; 36(6):668-9. PubMed ID: 6774884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spironolactone and canrenoate-K: relative potency at steady state.
    Ramsay L; Asbury M; Shelton J; Harrison I
    Clin Pharmacol Ther; 1977 May; 21(5):602-9. PubMed ID: 858213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antihypertensive and renal activities of potassium canrenoate are associated with increased renal prostaglandin excretion.
    Castellani S; Scarti L; Chen JL; Del Rosso A; Carnovali M; Masotti G
    Clin Sci (Lond); 1989 Aug; 77(2):217-22. PubMed ID: 2766661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disappearance of spironolactone-induced gynaecomastia during treatment with potassium canrenoate.
    Dupont A
    Lancet; 1985 Sep; 2(8457):731. PubMed ID: 2863716
    [No Abstract]   [Full Text] [Related]  

  • 10. In-vivo metabolites of spironolactone and potassium canrenoate: determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assay.
    Armanini D; Karbowiak I; Goi A; Mantero F; Funder JW
    Clin Endocrinol (Oxf); 1985 Oct; 23(4):341-7. PubMed ID: 4064345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic activity of potassium canrenoate in man.
    Yeh BK; Chiang BN; Sung PK
    Am Heart J; 1976 Sep; 92(3):308-14. PubMed ID: 949026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of K+-canrenoate on the development of DOCA-salt hypertension.
    Vargas F; Haro JM; Jodar E; Soler A; Garcia del Rio C
    J Pharm Pharmacol; 1989 May; 41(5):335-8. PubMed ID: 2569521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of potassium canrenoate on the EP and Na+, K+ activities in endolymph].
    Wakizono S; Komune S; Hisashi K; Uemura T
    Nihon Jibiinkoka Gakkai Kaiho; 1990 Mar; 93(3):373-80. PubMed ID: 2352044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical study of potassium canrenoate on raised intracranial pressure.
    Node Y; Nakazawa S
    Adv Neurol; 1990; 52():557. PubMed ID: 2396562
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of canrenoate K on corticosteroid biosynthesis in nephrectomized dogs.
    Lasaridis AN; Tourkantonis A; Spanos P; Apostolopoulou K; Pharmakiotis A
    J Steroid Biochem; 1984 Apr; 20(4A):923-9. PubMed ID: 6323885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of potassium canrenoate (Aldactone) on the norepinephrine metabolism and potassium ionic currents of the heart.
    Antalóczy Z; Sebeszta M; Préda I
    Adv Myocardiol; 1982; 3():215-22. PubMed ID: 6302766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effect of potassium canrenoate administration on renin-angiotensin, kallikrein-kinin and prostaglandin systems.
    Lahera V; Cachofeiro V; Duran F; Cañizo FJ; Rodriguez FJ; Tresguerres JA
    Gen Pharmacol; 1988; 19(6):835-9. PubMed ID: 3068096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of spironolactone and potassium canrenoate on cytosolic and nuclear androgen and estrogen receptors of rat liver.
    Francavilla A; Di Leo A; Eagon PK; Polimeno L; Guglielmi F; Fanizza G; Barone M; Starzl TE
    Gastroenterology; 1987 Oct; 93(4):681-6. PubMed ID: 3623016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of canrenoate-K and prorenoate-K upon aldosterone biosynthesis in perifused frog interrenal glands.
    Delarue C; Leboulenger F; Tonon MC; Jegou S; Leroux P; Kusmierek MC; Corvol P; Vaillant R; Vaudry H
    Steroids; 1979 Sep; 34(3):319-32. PubMed ID: 494369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of adrenal and gonadal steroids and K+-canrenoate on the metabolism of aldosterone by rat liver microsomes.
    Latif SA; McDermott MJ; Morris DJ
    Steroids; 1983 Sep; 42(3):283-97. PubMed ID: 6673191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.